Funding Opportunity Announcement - NIBIB Technology Development Networks
National Institutes of Health
At a glance
This funding opportunity is offered by National Institutes of Health. Awards are up to $1,000,000.
Classification and identifiers
- Solicitation number
- RFA-EB-26-001
- Assistance listing (CFDA)
- 93.286
Amount
$1,000,000
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
About this opportunity
The NIBIB intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for NIBIB Technology Development Network Coordinating Centers. These Coordinating Centers are designed to bring scientific and engineering communities together to solve translational problems. The Coordinating Centers will be responsible for enhancing integration between components of the Network by facilitating opportunities for collaborations across technology development projects. Also, the Coordinating Centers will disseminate program advances, develop resources and outreach strategies for engaging the broader biomedical research community, and manage an Opportunity Funds program to rapidly fund and support promising small-scale work that advances translational development of innovative platform...
Related opportunities
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of Health
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of HealthCloses in 63 days
- Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)National Institutes of Health
- NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)National Institutes of Health
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)National Institutes of HealthCloses Aug 2027